286 related articles for article (PubMed ID: 15860657)
41. Isoflavones inhibit nicotine C-oxidation catalyzed by human CYP2A6.
Nakajima M; Itoh M; Yamanaka H; Fukami T; Tokudome S; Yamamoto Y; Yamamoto H; Yokoi T
J Clin Pharmacol; 2006 Mar; 46(3):337-44. PubMed ID: 16490810
[TBL] [Abstract][Full Text] [Related]
42. Metabolism of nicotine by human liver microsomes: stereoselective formation of trans-nicotine N'-oxide.
Cashman JR; Park SB; Yang ZC; Wrighton SA; Jacob P; Benowitz NL
Chem Res Toxicol; 1992; 5(5):639-46. PubMed ID: 1446003
[TBL] [Abstract][Full Text] [Related]
43. Roles of human CYP2A6 and rat CYP2B1 in the oxidation of (+)-fenchol by liver microsomes.
Miyazawa M; Gyoubu K
Xenobiotica; 2007 Sep; 37(9):943-53. PubMed ID: 17992728
[TBL] [Abstract][Full Text] [Related]
44. Structure-Function Studies of Naphthalene, Phenanthrene, Biphenyl, and Their Derivatives in Interaction with and Oxidation by Cytochromes P450 2A13 and 2A6.
Shimada T; Takenaka S; Kakimoto K; Murayama N; Lim YR; Kim D; Foroozesh MK; Yamazaki H; Guengerich FP; Komori M
Chem Res Toxicol; 2016 Jun; 29(6):1029-40. PubMed ID: 27137136
[TBL] [Abstract][Full Text] [Related]
45. Nicotine-related alkaloids and metabolites as inhibitors of human cytochrome P-450 2A6.
Denton TT; Zhang X; Cashman JR
Biochem Pharmacol; 2004 Feb; 67(4):751-6. PubMed ID: 14757175
[TBL] [Abstract][Full Text] [Related]
46. Metabolism of nicotine in rat lung microvascular endothelial cells.
Ochiai Y; Sakurai E; Nomura A; Itoh K; Tanaka Y
J Pharm Pharmacol; 2006 Mar; 58(3):403-7. PubMed ID: 16536909
[TBL] [Abstract][Full Text] [Related]
47. Effects of eleven isothiocyanates on P450 2A6- and 2A13-catalyzed coumarin 7-hydroxylation.
von Weymarn LB; Chun JA; Knudsen GA; Hollenberg PF
Chem Res Toxicol; 2007 Sep; 20(9):1252-9. PubMed ID: 17672516
[TBL] [Abstract][Full Text] [Related]
48. The novel assay method for nicotine metabolism to cotinine using high performance liquid chromatography.
Miyazawa M; Kawauchi Y; Okuno Y; Oda Y
Chem Pharm Bull (Tokyo); 2011; 59(3):295-7. PubMed ID: 21372408
[TBL] [Abstract][Full Text] [Related]
49. Mechanism-based inactivation of human liver cytochrome P450 2A6 by 8-methoxypsoralen.
Koenigs LL; Peter RM; Thompson SJ; Rettie AE; Trager WF
Drug Metab Dispos; 1997 Dec; 25(12):1407-15. PubMed ID: 9394031
[TBL] [Abstract][Full Text] [Related]
50. Influence of menstrual cycle on cytochrome P450 2A6 activity and cardiovascular effects of nicotine.
Hukkanen J; Gourlay SG; Kenkare S; Benowitz NL
Clin Pharmacol Ther; 2005 Mar; 77(3):159-69. PubMed ID: 15735610
[TBL] [Abstract][Full Text] [Related]
51. Characterization and comparison of nicotine and cotinine metabolism in vitro and in vivo in DBA/2 and C57BL/6 mice.
Siu EC; Tyndale RF
Mol Pharmacol; 2007 Mar; 71(3):826-34. PubMed ID: 17158199
[TBL] [Abstract][Full Text] [Related]
52. Interindividual differences in nicotine metabolism and genetic polymorphisms of human CYP2A6.
Nakajima M; Kuroiwa Y; Yokoi T
Drug Metab Rev; 2002 Nov; 34(4):865-77. PubMed ID: 12487152
[TBL] [Abstract][Full Text] [Related]
53. Evaluation of methoxsalen, tranylcypromine, and tryptamine as specific and selective CYP2A6 inhibitors in vitro.
Zhang W; Kilicarslan T; Tyndale RF; Sellers EM
Drug Metab Dispos; 2001 Jun; 29(6):897-902. PubMed ID: 11353760
[TBL] [Abstract][Full Text] [Related]
54. Genetic variability in CYP2A6 and the pharmacokinetics of nicotine.
Mwenifumbo JC; Tyndale RF
Pharmacogenomics; 2007 Oct; 8(10):1385-402. PubMed ID: 17979512
[TBL] [Abstract][Full Text] [Related]
55. In vitro metabolism of N'-Nitrosonornicotine catalyzed by cytochrome P450 2A13 and its inhibition by nicotine, N'-Nitrosoanatabine and N'-Nitrosoanabasine.
Liu X; Zhang J; Wang L; Yang B; Zhang C; Liu W; Zhou J
Chem Biol Interact; 2016 Dec; 260():263-269. PubMed ID: 27567546
[TBL] [Abstract][Full Text] [Related]
56. A LC-MS/MS method for concurrent determination of nicotine metabolites and role of CYP2A6 in nicotine metabolism in U937 macrophages: implications in oxidative stress in HIV + smokers.
Jin M; Earla R; Shah A; Earla RL; Gupte R; Mitra AK; Kumar A; Kumar S
J Neuroimmune Pharmacol; 2012 Mar; 7(1):289-99. PubMed ID: 21655912
[TBL] [Abstract][Full Text] [Related]
57. An LC-MS/MS method for concurrent determination of nicotine metabolites and the role of CYP2A6 in nicotine metabolite-mediated oxidative stress in SVGA astrocytes.
Ande A; Earla R; Jin M; Silverstein PS; Mitra AK; Kumar A; Kumar S
Drug Alcohol Depend; 2012 Sep; 125(1-2):49-59. PubMed ID: 22498344
[TBL] [Abstract][Full Text] [Related]
58. Expression of cytochrome P450 2A3 in rat esophagus: relevance to N-nitrosobenzylmethylamine.
Gopalakrishnan R; Morse MA; Lu J; Weghorst CM; Sabourin CL; Stoner GD; Murphy SE
Carcinogenesis; 1999 May; 20(5):885-91. PubMed ID: 10334207
[TBL] [Abstract][Full Text] [Related]
59. Determination of the nicotine metabolites cotinine and trans-3'-hydroxycotinine in biologic fluids of smokers and non-smokers using liquid chromatography-tandem mass spectrometry: biomarkers for tobacco smoke exposure and for phenotyping cytochrome P450 2A6 activity.
Jacob P; Yu L; Duan M; Ramos L; Yturralde O; Benowitz NL
J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Feb; 879(3-4):267-76. PubMed ID: 21208832
[TBL] [Abstract][Full Text] [Related]
60. [Absorption, metabolism and excretion of nicotine in humans].
Sobkowiak R; Lesicki A
Postepy Biochem; 2013; 59(1):33-44. PubMed ID: 23821941
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
